1. Arnaout HH, Khorshied MM, Reda Korshid OM, El-Nagdy MH. Association of caspase 8 and caspase 10 genetic polymorphisms with B-cell non Hodgkin’s lymphoma in Egypt: a case-control study. J Cancer Sci Ther. 2012;4(9):249–53.
2. Choi JY, Kim JG, Lee YJ, Chae YS, Sohn SK, Moon JH, Kang BW, Jung MK, Jeon SW, Park JS, Choi GS. Prognostic impact of polymorphisms in the CASPASE genes on survival of patients with colorectal cancer. Cancer Res Treat. 2012;44(1):32–6.
3. Dorsey FC, Steeves MA, Cleveland JL. Apoptosis, autophagy, and necrosis. In: Mendesohn J, Howley PM, Israel MA, Gray JW, Thompson CB, editors. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier; 2008. p. 207–10.
4. Forero-Torres A, Shah J, Wood T, Posey J, Carlisle R, Copigneaux C, Luo FR, Wojtowicz-Praga S, Percent I, Saleh M. Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5). Cancer Biother Radiopharm. 2010;25(1):13–9.
5. Green DR. Means to an end: apoptosis and other cell death mechanisms. New York: Cold Spring Harbor Laboratory Press; 2011. p. 5–28.